| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amphastar Pharmaceuticals, Inc. (AMPH) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. AMPH is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.00M | $59.22M | - | |
| CFO | 177.0K | $3.49M | - | |
| VP | 172.8K | $3.41M | - | |
| VP | 122.9K | $2.43M | - | |
| Dir | 71.4K | $1.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2018 | Shandell Jason B. | President And General Counsel | Sell | 18,627 | $19.42 | $361,747.11 | -4.0% | |
| Dec 19, 2017 | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 523 | $19.48 | $10,185.63 | -1.7% | |
| Dec 14, 2017 | Shohet Stephen B. | Director | Sale+OE | 7,866 | $18.87 | $148,429.85 | -24.6% | |
| Dec 12, 2017 | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 523 | $18.96 | $9,916.92 | -1.7% | |
| Dec 7, 2017 | Shohet Stephen B. | Director | Sale+OE | 7,862 | $18.34 | $144,209.52 | -24.6% | |
| Dec 1, 2017 | Peters William J52 | CFO, SVP &Treasurer | Sell | 6,226 | $19.67 | $122,465.42 | -7.4% | |
| Nov 30, 2017 | Shohet Stephen B. | Director | Sale+OE | 7,862 | $19.25 | $151,344.29 | -24.6% | |
| Nov 28, 2017 | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 523 | $18.15 | $9,492.76 | -1.6% | |
| Nov 22, 2017 | Shohet Stephen B. | Director | Sale+OE | 7,862 | $18.94 | $148,895.27 | -24.6% | |
| Nov 21, 2017 | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 523 | $18.81 | $9,839.25 | -1.6% |